| Name: | Erythromycin EP Impurity F |
| Catalogue No. | VL690011 |
| CAS No. | 105882-69-7 |
| Molecular Formula | C₃₇H₆₅NO₁₂ |
| Molecular Weight | 715.91 |
| Status | In-stock |
| IUPAC Name | (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one |
| Synonyms | Pseudoerythromycin A Enol Ether |
| Appearance | Light Orange Powder |
| Description | Erythromycin EP Impurity F (CAS No: 105882-69-7) or Pseudoerythromycin A Enol Ether is formed during the fermentation of Erythromycin during its synthesis. Erythromycin is a complex macrolide antibiotic that is mainly effective against Grampositive bacteria and has only limited activity against Gram-negative bacteria. |
| References | Kumar Chitneni, Satish, et al. “Identification of Impurities in Erythromycin by Liquid Chromatography–Mass Spectrometric Detection.” Journal of Chromatography A, vol. 1056, no. 1-2, Nov. 2004, pp. 111–20, https://doi.org/10.1016/j.chroma.2004.07.091. |
